MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fimmu.2025.1470488

Медицинская библиотека · Frontiers in immunology · 2025

Update on tocilizumab in rheumatoid arthritis: a narrative review.

Parisi Simone, Ditto Maria Chiara, Ghellere Francesco, Panaro Salvatore, Piccione Francesca, Borrelli Richard, Fusaro Enrico

СтатьяОбзорПеревод в очереди

Аннотация

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint pain, swelling, and stiffness, affecting approximately 1% of the adult population. Tocilizumab (TCZ), a monoclonal antibody targeting the IL-6 receptor, has emerged as an effective treatment for RA. This narrative review provides an update on TCZ's efficacy and safety based on data from randomized controlled trials (RCTs) and real-world evidence (RWE). TCZ, available in subcutaneous (SC) and intravenous (IV) formulations, has shown significant benefits in RA management. Key clinical trials, including SAMURAI, OPTION, RADIATE, and TOWARD, have demonstrated TCZ's efficacy as monotherapy and in combination with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), particularly in patients with inadequate responses to methotrexate or TNF inhibitors. Long-term studies, such as STREAM, have highlighted TCZ's sustained efficacy and favorable safety profile over 5 years. The impact of TCZ on cardiovascular health, lipid profiles, and the risk of infections has been a focal point, with findings suggesting no significant increase in cardiovascular disease risk compared to other RA therapies. RWE further highlights the effectiveness of TCZ, identifying predictors of response, such as age, and emphasizes its suitability for biologic-naïve and overweight patients. Special considerations include TCZ use in RA-associated interstitial lung disease and amyloidosis. Overall, TCZ remains a pivotal option in RA treatment, with a well-established safety and efficacy profile supported by extensive clinical and real-world data.

Для цитирования: Parisi Simone, Ditto Maria Chiara, Ghellere Francesco, Panaro Salvatore, Piccione Francesca, Borrelli Richard, Fusaro Enrico. Update on tocilizumab in rheumatoid arthritis: a narrative review.. Frontiers in immunology. 2025. DOI: 10.3389/fimmu.2025.1470488.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.